Oncoimmunology

ISSN	2162-402X
ISSN-L	2162-4011
IUID	782c902f31cb42be97c4bd068451f0a2
Modified	2020-11-27T13:12:59.274Z
Created	2018-12-05T11:05:21.118Z

Year 2024

PubMed DOI Crossref

Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.

Feodoroff M, Hamdan F, Antignani G, ..., Grönholm M, Cerullo V

Oncoimmunology 13 (1) 2407532 [2024-09-25; online 2024-09-25]

PubMed DOI Crossref

Selective lysis of acute myeloid leukemia cells by CD34/CD3 bispecific antibody through the activation of γδ T-cells.

Al Agrafi F, Gaballa A, Hahn P, ..., Uhlin M, Stikvoort A

Oncoimmunology 13 (1) 2379063 [2024-07-27; online 2024-07-27]

Year 2022

PubMed DOI Crossref

Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-tumor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response.

Jin C, Ali A, Iskantar A, ..., Karlsson-Parra A, Yu D

Oncoimmunology 11 (1) 2099642 [2022-07-13; online 2022-07-13]

PubMed DOI Crossref

Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress.

Cedervall J, Herre M, Dragomir A, ..., Larsson A, Olsson AK

Oncoimmunology 11 (1) 2049487 [2022-03-14; online 2022-03-14]

Year 2021

PubMed DOI Crossref

Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients.

Van Wigcheren GF, De Haas N, Mulder TA, ..., Hato SV, De Vries IJM

Oncoimmunology 10 (1) 1935557 [2021-06-27; online 2021-06-27]

Year 2020

PubMed DOI Crossref

Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy.

Daillère R, Derosa L, Bonvalet M, ..., Kroemer G, Zitvogel L

Oncoimmunology 9 (1) 1774298 [2020-06-03; online 2020-06-03]

PubMed DOI Crossref

Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy.

Georganaki M, Ramachandran M, Tuit S, ..., Tugues S, Dimberg A

Oncoimmunology 9 (1) 1730538 [2020-03-09; online 2020-03-09]

Year 2019

PubMed DOI Crossref

Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors.

Kaffes I, Szulzewsky F, Chen Z, ..., Brat DJ, Hambardzumyan D

Oncoimmunology 8 (11) e1655360 [2019-08-22; online 2019-08-22]

Year 2018

PubMed DOI Crossref

Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics.

Jabeen S, Espinoza JA, Torland LA, ..., Gromova I, Tekpli X

Oncoimmunology 8 (2) e1537691 [2018-11-05; online 2018-11-05]

Year 2017

PubMed DOI Crossref

Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models.

Fotaki G, Jin C, Kerzeli IK, ..., Yu D, Essand M

Oncoimmunology 7 (3) e1397250 [2017-12-26; online 2017-12-26]

PubMed DOI Crossref

Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses.

Fotaki G, Jin C, Ramachandran M, ..., Yu D, Essand M

Oncoimmunology 7 (3) e1395126 [2017-11-27; online 2017-11-27]

PubMed DOI Crossref

Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice.

Cedervall J, Dragomir A, Saupe F, ..., Larsson A, Olsson AK

Oncoimmunology 6 (8) e1320009 [2017-04-20; online 2017-04-20]

Year 2016

PubMed DOI Crossref

Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.

Espinoza JA, Jabeen S, Batra R, ..., Kristensen VN, Gromova I

Oncoimmunology 5 (12) e1248015 [2016-10-24; online 2016-10-24]

Affiliated researcher

PubMed DOI Crossref

Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade.

Eissler N, Mao Y, Brodin D, ..., Kiessling R, Kogner P

Oncoimmunology 5 (12) e1232222 [2016-09-09; online 2016-09-09]

PubMed DOI Crossref

Dynamic alterations of bone marrow cytokine landscape of myelodysplastic syndromes patients treated with 5-azacytidine.

Moudra A, Hubackova S, Machalova V, ..., Hodny Z, Jonasova A

Oncoimmunology 5 (10) e1183860 [2016-05-13; online 2016-05-13]

PubMed DOI Crossref

Tumor-induced neutrophil extracellular traps-drivers of systemic inflammation and vascular dysfunction.

Cedervall J, Dimberg A, Olsson AK

Oncoimmunology 5 (3) e1098803 [2016-03-00; online 2015-10-29]

Year 2013

DOI Crossref

Cyclooxygenase-2

Mao Y, Poschke I, Kiessling R

Oncoimmunology 2 (8) e25157 [2013-08-00; online 2014-10-27]

SciLifeLab Fellow Yumeng Mao

Year 2012

PubMed DOI Crossref

Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients.

de Boniface J, Mao Y, Schmidt-Mende J, Kiessling R, Poschke I

Oncoimmunology 1 (8) 1305-1312 [2012-11-01; online 2012-12-18]

SciLifeLab Fellow Yumeng Mao

PubMed DOI Crossref

Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells.

Kiessling R, Okita R, Mougiakakos D, ..., Mimura K, Kono K

Oncoimmunology 1 (7) 1200-1201 [2012-10-01; online 2012-11-22]

SciLifeLab Fellow Yumeng Mao